 | • レポートコード：GIR-23F0663 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Immune Globulin Subcutaneous Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の皮下注用人免疫グロブリン製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 皮下注用人免疫グロブリン製剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・2g、4g、10g、その他 アプリケーション別セグメントは次のように区分されます。 ・免疫不全、自己免疫疾患、急性感染症 世界の皮下注用人免疫グロブリン製剤市場の主要なマーケットプレーヤーは以下のとおりです。 ・Takeda、CSL 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 皮下注用人免疫グロブリン製剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：2g、4g、10g、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症 - 世界の皮下注用人免疫グロブリン製剤市場規模・予測 - 世界の皮下注用人免疫グロブリン製剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Takeda、CSL ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：2g、4g、10g、その他 ・アプリケーション別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症 ・皮下注用人免疫グロブリン製剤の北米市場分析 - 皮下注用人免疫グロブリン製剤の北米市場：タイプ別市場規模2017年-2028年 - 皮下注用人免疫グロブリン製剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・皮下注用人免疫グロブリン製剤のヨーロッパ市場分析 - ：皮下注用人免疫グロブリン製剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：皮下注用人免疫グロブリン製剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・皮下注用人免疫グロブリン製剤のアジア太平洋市場分析 - 皮下注用人免疫グロブリン製剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 皮下注用人免疫グロブリン製剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・皮下注用人免疫グロブリン製剤の南米市場分析 - 皮下注用人免疫グロブリン製剤の南米市場：タイプ別市場規模2017年-2028年 - 皮下注用人免疫グロブリン製剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・皮下注用人免疫グロブリン製剤の中東・アフリカ市場分析 - 皮下注用人免疫グロブリン製剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 皮下注用人免疫グロブリン製剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Immune Globulin Subcutaneous market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immune Globulin Subcutaneous market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the Immune Globulin Subcutaneous global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2g segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immune Globulin Subcutaneous include Takeda, CSL, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immune Globulin Subcutaneous market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2g
4g
10g
Other
Market segment by Application can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The key market players for global Immune Globulin Subcutaneous market are listed below:
Takeda
CSL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immune Globulin Subcutaneous product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immune Globulin Subcutaneous, with price, sales, revenue and global market share of Immune Globulin Subcutaneous from 2019 to 2022.
Chapter 3, the Immune Globulin Subcutaneous competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Globulin Subcutaneous breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immune Globulin Subcutaneous market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Globulin Subcutaneous.
Chapter 13, 14, and 15, to describe Immune Globulin Subcutaneous sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Immune Globulin Subcutaneous Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immune Globulin Subcutaneous Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2g
1.2.3 4g
1.2.4 10g
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Immune Globulin Subcutaneous Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Subcutaneous Market Size & Forecast
1.4.1 Global Immune Globulin Subcutaneous Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immune Globulin Subcutaneous Sales in Volume (2017-2028)
1.4.3 Global Immune Globulin Subcutaneous Price (2017-2028)
1.5 Global Immune Globulin Subcutaneous Production Capacity Analysis
1.5.1 Global Immune Globulin Subcutaneous Total Production Capacity (2017-2028)
1.5.2 Global Immune Globulin Subcutaneous Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immune Globulin Subcutaneous Market Drivers
1.6.2 Immune Globulin Subcutaneous Market Restraints
1.6.3 Immune Globulin Subcutaneous Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Immune Globulin Subcutaneous Product and Services
2.1.4 Takeda Immune Globulin Subcutaneous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Immune Globulin Subcutaneous Product and Services
2.2.4 CSL Immune Globulin Subcutaneous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immune Globulin Subcutaneous Breakdown Data by Manufacturer
3.1 Global Immune Globulin Subcutaneous Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immune Globulin Subcutaneous Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immune Globulin Subcutaneous
3.4 Market Concentration Rate
3.4.1 Top 3 Immune Globulin Subcutaneous Manufacturer Market Share in 2021
3.4.2 Top 6 Immune Globulin Subcutaneous Manufacturer Market Share in 2021
3.5 Global Immune Globulin Subcutaneous Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immune Globulin Subcutaneous Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immune Globulin Subcutaneous Market Size by Region
4.1.1 Global Immune Globulin Subcutaneous Sales in Volume by Region (2017-2028)
4.1.2 Global Immune Globulin Subcutaneous Revenue by Region (2017-2028)
4.2 North America Immune Globulin Subcutaneous Revenue (2017-2028)
4.3 Europe Immune Globulin Subcutaneous Revenue (2017-2028)
4.4 Asia-Pacific Immune Globulin Subcutaneous Revenue (2017-2028)
4.5 South America Immune Globulin Subcutaneous Revenue (2017-2028)
4.6 Middle East and Africa Immune Globulin Subcutaneous Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immune Globulin Subcutaneous Sales in Volume by Type (2017-2028)
5.2 Global Immune Globulin Subcutaneous Revenue by Type (2017-2028)
5.3 Global Immune Globulin Subcutaneous Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immune Globulin Subcutaneous Sales in Volume by Application (2017-2028)
6.2 Global Immune Globulin Subcutaneous Revenue by Application (2017-2028)
6.3 Global Immune Globulin Subcutaneous Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immune Globulin Subcutaneous Sales by Type (2017-2028)
7.2 North America Immune Globulin Subcutaneous Sales by Application (2017-2028)
7.3 North America Immune Globulin Subcutaneous Market Size by Country
7.3.1 North America Immune Globulin Subcutaneous Sales in Volume by Country (2017-2028)
7.3.2 North America Immune Globulin Subcutaneous Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immune Globulin Subcutaneous Sales by Type (2017-2028)
8.2 Europe Immune Globulin Subcutaneous Sales by Application (2017-2028)
8.3 Europe Immune Globulin Subcutaneous Market Size by Country
8.3.1 Europe Immune Globulin Subcutaneous Sales in Volume by Country (2017-2028)
8.3.2 Europe Immune Globulin Subcutaneous Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immune Globulin Subcutaneous Sales by Type (2017-2028)
9.2 Asia-Pacific Immune Globulin Subcutaneous Sales by Application (2017-2028)
9.3 Asia-Pacific Immune Globulin Subcutaneous Market Size by Region
9.3.1 Asia-Pacific Immune Globulin Subcutaneous Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immune Globulin Subcutaneous Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immune Globulin Subcutaneous Sales by Type (2017-2028)
10.2 South America Immune Globulin Subcutaneous Sales by Application (2017-2028)
10.3 South America Immune Globulin Subcutaneous Market Size by Country
10.3.1 South America Immune Globulin Subcutaneous Sales in Volume by Country (2017-2028)
10.3.2 South America Immune Globulin Subcutaneous Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immune Globulin Subcutaneous Sales by Type (2017-2028)
11.2 Middle East & Africa Immune Globulin Subcutaneous Sales by Application (2017-2028)
11.3 Middle East & Africa Immune Globulin Subcutaneous Market Size by Country
11.3.1 Middle East & Africa Immune Globulin Subcutaneous Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immune Globulin Subcutaneous Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immune Globulin Subcutaneous and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immune Globulin Subcutaneous
12.3 Immune Globulin Subcutaneous Production Process
12.4 Immune Globulin Subcutaneous Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immune Globulin Subcutaneous Typical Distributors
13.3 Immune Globulin Subcutaneous Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Immune Globulin Subcutaneous Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Immune Globulin Subcutaneous Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Immune Globulin Subcutaneous Product and Services
Table 6. Takeda Immune Globulin Subcutaneous Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Immune Globulin Subcutaneous Product and Services
Table 10. CSL Immune Globulin Subcutaneous Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Immune Globulin Subcutaneous Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 12. Global Immune Globulin Subcutaneous Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Immune Globulin Subcutaneous, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Immune Globulin Subcutaneous Production Capacity by Company, (MT): 2020 VS 2021
Table 15. Head Office and Immune Globulin Subcutaneous Production Site of Key Manufacturer
Table 16. Immune Globulin Subcutaneous New Entrant and Capacity Expansion Plans
Table 17. Immune Globulin Subcutaneous Mergers & Acquisitions in the Past Five Years
Table 18. Global Immune Globulin Subcutaneous Sales by Region (2017-2022) & (MT)
Table 19. Global Immune Globulin Subcutaneous Sales by Region (2023-2028) & (MT)
Table 20. Global Immune Globulin Subcutaneous Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Immune Globulin Subcutaneous Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 23. Global Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 24. Global Immune Globulin Subcutaneous Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Immune Globulin Subcutaneous Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Immune Globulin Subcutaneous Price by Type (2017-2022) & (USD/Kg)
Table 27. Global Immune Globulin Subcutaneous Price by Type (2023-2028) & (USD/Kg)
Table 28. Global Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 29. Global Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 30. Global Immune Globulin Subcutaneous Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Immune Globulin Subcutaneous Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Immune Globulin Subcutaneous Price by Application (2017-2022) & (USD/Kg)
Table 33. Global Immune Globulin Subcutaneous Price by Application (2023-2028) & (USD/Kg)
Table 34. North America Immune Globulin Subcutaneous Sales by Country (2017-2022) & (MT)
Table 35. North America Immune Globulin Subcutaneous Sales by Country (2023-2028) & (MT)
Table 36. North America Immune Globulin Subcutaneous Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Immune Globulin Subcutaneous Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 39. North America Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 40. North America Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 41. North America Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 42. Europe Immune Globulin Subcutaneous Sales by Country (2017-2022) & (MT)
Table 43. Europe Immune Globulin Subcutaneous Sales by Country (2023-2028) & (MT)
Table 44. Europe Immune Globulin Subcutaneous Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Immune Globulin Subcutaneous Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 47. Europe Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 48. Europe Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 49. Europe Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 50. Asia-Pacific Immune Globulin Subcutaneous Sales by Region (2017-2022) & (MT)
Table 51. Asia-Pacific Immune Globulin Subcutaneous Sales by Region (2023-2028) & (MT)
Table 52. Asia-Pacific Immune Globulin Subcutaneous Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Immune Globulin Subcutaneous Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 55. Asia-Pacific Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 56. Asia-Pacific Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 57. Asia-Pacific Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 58. South America Immune Globulin Subcutaneous Sales by Country (2017-2022) & (MT)
Table 59. South America Immune Globulin Subcutaneous Sales by Country (2023-2028) & (MT)
Table 60. South America Immune Globulin Subcutaneous Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Immune Globulin Subcutaneous Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 63. South America Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 64. South America Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 65. South America Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 66. Middle East & Africa Immune Globulin Subcutaneous Sales by Region (2017-2022) & (MT)
Table 67. Middle East & Africa Immune Globulin Subcutaneous Sales by Region (2023-2028) & (MT)
Table 68. Middle East & Africa Immune Globulin Subcutaneous Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Immune Globulin Subcutaneous Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Immune Globulin Subcutaneous Sales by Type (2017-2022) & (MT)
Table 71. Middle East & Africa Immune Globulin Subcutaneous Sales by Type (2023-2028) & (MT)
Table 72. Middle East & Africa Immune Globulin Subcutaneous Sales by Application (2017-2022) & (MT)
Table 73. Middle East & Africa Immune Globulin Subcutaneous Sales by Application (2023-2028) & (MT)
Table 74. Immune Globulin Subcutaneous Raw Material
Table 75. Key Manufacturers of Immune Globulin Subcutaneous Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Immune Globulin Subcutaneous Typical Distributors
Table 79. Immune Globulin Subcutaneous Typical Customers
List of Figures
Figure 1. Immune Globulin Subcutaneous Picture
Figure 2. Global Immune Globulin Subcutaneous Revenue Market Share by Type in 2021
Figure 3. 2g
Figure 4. 4g
Figure 5. 10g
Figure 6. Other
Figure 7. Global Immune Globulin Subcutaneous Revenue Market Share by Application in 2021
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Immune Globulin Subcutaneous Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 12. Global Immune Globulin Subcutaneous Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Immune Globulin Subcutaneous Sales (2017-2028) & (MT)
Figure 14. Global Immune Globulin Subcutaneous Price (2017-2028) & (USD/Kg)
Figure 15. Global Immune Globulin Subcutaneous Production Capacity (2017-2028) & (MT)
Figure 16. Global Immune Globulin Subcutaneous Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Immune Globulin Subcutaneous Market Drivers
Figure 18. Immune Globulin Subcutaneous Market Restraints
Figure 19. Immune Globulin Subcutaneous Market Trends
Figure 20. Global Immune Globulin Subcutaneous Sales Market Share by Manufacturer in 2021
Figure 21. Global Immune Globulin Subcutaneous Revenue Market Share by Manufacturer in 2021
Figure 22. Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Immune Globulin Subcutaneous Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Immune Globulin Subcutaneous Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Immune Globulin Subcutaneous Sales Market Share by Region (2017-2028)
Figure 26. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2017-2028)
Figure 27. North America Immune Globulin Subcutaneous Revenue (2017-2028) & (USD Million)
Figure 28. Europe Immune Globulin Subcutaneous Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Immune Globulin Subcutaneous Revenue (2017-2028) & (USD Million)
Figure 30. South America Immune Globulin Subcutaneous Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Immune Globulin Subcutaneous Revenue (2017-2028) & (USD Million)
Figure 32. Global Immune Globulin Subcutaneous Sales Market Share by Type (2017-2028)
Figure 33. Global Immune Globulin Subcutaneous Revenue Market Share by Type (2017-2028)
Figure 34. Global Immune Globulin Subcutaneous Price by Type (2017-2028) & (USD/Kg)
Figure 35. Global Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 36. Global Immune Globulin Subcutaneous Revenue Market Share by Application (2017-2028)
Figure 37. Global Immune Globulin Subcutaneous Price by Application (2017-2028) & (USD/Kg)
Figure 38. North America Immune Globulin Subcutaneous Sales Market Share by Type (2017-2028)
Figure 39. North America Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 40. North America Immune Globulin Subcutaneous Sales Market Share by Country (2017-2028)
Figure 41. North America Immune Globulin Subcutaneous Revenue Market Share by Country (2017-2028)
Figure 42. United States Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Immune Globulin Subcutaneous Sales Market Share by Type (2017-2028)
Figure 46. Europe Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 47. Europe Immune Globulin Subcutaneous Sales Market Share by Country (2017-2028)
Figure 48. Europe Immune Globulin Subcutaneous Revenue Market Share by Country (2017-2028)
Figure 49. Germany Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Immune Globulin Subcutaneous Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Immune Globulin Subcutaneous Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Immune Globulin Subcutaneous Revenue Market Share by Region (2017-2028)
Figure 58. China Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Immune Globulin Subcutaneous Sales Market Share by Type (2017-2028)
Figure 65. South America Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 66. South America Immune Globulin Subcutaneous Sales Market Share by Country (2017-2028)
Figure 67. South America Immune Globulin Subcutaneous Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Immune Globulin Subcutaneous Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Immune Globulin Subcutaneous Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Immune Globulin Subcutaneous Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Immune Globulin Subcutaneous Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Immune Globulin Subcutaneous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Immune Globulin Subcutaneous in 2021
Figure 79. Manufacturing Process Analysis of Immune Globulin Subcutaneous
Figure 80. Immune Globulin Subcutaneous Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
• 日本語訳：皮下注用人免疫グロブリン製剤のグローバル市場2022年
• レポートコード：GIR-23F0663 ▷ お問い合わせ（見積依頼・ご注文・質問）